Therapeutic potential of adult bone marrow stem cells in liver disease and delivery approaches.
Hematopoietic stem cells (HSCs) and mesenchymal stem cell (MSCs) are two main subtypes of bone marrow stem cells. Extensive studies have been carried out to investigate the therapeutic potential of BMSCs in liver disease. A number of animal and human studies demonstrated that either HSCs or MSCs could be applied to therapeutic purposes in certain liver diseases. The diseased liver may recruit migratory stem cells, particularly from the bone marrow, to generate hepatocyte-like cells either by transdifferentiation or cell fusion. Transplantation of BMSCs has therapeutic effects of restoration of liver mass and function, alleviation of fibrosis and correction of inherited liver diseases. There are still controversial results over the potential effects of BMSCs on liver diseases, and some of the discrepancies are thought to be lied in the differences of experimental protocols, differences in individual research laboratory, and the uncertainties of the techniques employed. Several potential approaches for BMSCs delivery in liver diseases have been proposed in animal studies and human trials. BMSCs can be delivered via intraportal vein, systemic infusion, intraperitoneal, intrahepatic, intrasplenic. The optimal stem cells delivery should be easy to perform, less invasive and traumatic, minimum side effects, and with high cells survival rate. In this review, we focus on the up-to-date evidence of therapeutic effects of BMSCs on liver disease, the characteristics of various delivery approaches, and the considerations for future studies.
Xu
You Qing
YQ
Department of Gastroenterology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China.
Liu
Zun Chang
ZC
D000328:Adult; D053687:Adult Stem Cells / Q000473:pathology / Q000637:transplantation*; D000818:Animals; D001854:Bone Marrow Cells / Q000473:pathology; D016026:Bone Marrow Transplantation / Q000379:methods; D054338:Cell Transdifferentiation; D015316:Genetic Therapy; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D008107:Liver Diseases / Q000628:therapy*; D059630:Mesenchymal Stem Cells / Q000473:pathology; D044968:Regenerative Medicine; D033581:Stem Cell Transplantation / Q000379:methods*